(Q40723520)

23 September 2017

title

Synthesis, cytotoxicity and antiviral activity of N,N'-bis-5-nitropyrimidyl derivatives of dispirotripiperazine (English)

1 reference

23 September 2017

Schmidtke M

1

1 reference

23 September 2017

Riabova O

2

1 reference

23 September 2017

Dahse HM

3

1 reference

23 September 2017

Stelzner A

4

1 reference

23 September 2017

Makarov V

5

1 reference

23 September 2017

language of work or name

1 reference

1 July 2002

1 reference

23 September 2017

1 reference

23 September 2017

volume

55

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

117-127

1 reference

Susceptibilities of several drug-resistant herpes simplex virus type 1 strains to alternative antiviral compounds

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: a controlled 6-month clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy] phenyl]-N'-pentylurea and analogues. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Recent developments in HIV protease inhibitor therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Treatment of human enterovirus infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Current research on respiratory viral infections: Third International Symposium

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Genetic risks of antiviral nucleoside analogues--a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Respiratory syncytial virus (RSV) disease and prospects for its control

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

Therapy of chronic hepatitis B virus infection: inhibition of the viral polymerase and other antiviral strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2802%2900014-1

7 January 2021

10.1016/S0166-3542(02)00014-1

Identifiers

DOI

1 reference

23 September 2017

1 reference